港股異動丨互聯網醫療股重挫 央媒提出有效保障互聯網處方用藥安全
格隆匯8月20日丨互聯網醫療股重挫,平安好醫生跌9.69%,阿里健康跌近6%,京東健康跌3.76%。人民時評刊文稱,目前,我國各類互聯網醫院已達1600多家,通過互聯網醫院複診購藥日益普及。在互聯網上嚴守處方藥到患者的“最後一公里”,確保用藥安全,事關人民羣眾身體健康,也是推動“互聯網+醫療健康”新業態健康有序發展的重要方面。加快完善互聯網診療、處方用藥辦法,更好保障就醫購藥服務需求,讓人們在線上線下都能安心就醫購藥,我們就能以行動不斷提高人民健康水平,推進健康中國建設。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.